• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析器复用对血液透析中补体激活和中性粒细胞减少的影响。

Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.

作者信息

Stroncek D F, Keshaviah P, Craddock P R, Hammerschmidt D E

出版信息

J Lab Clin Med. 1984 Sep;104(3):304-11.

PMID:6470561
Abstract

A prospective study of 10 patients undergoing hemodialysis showed that less neutropenia and complement activation occurred with dialyzer reuse. Neutrophil counts fell 95% +/- 5% (SEM) with first use and 66% +/- 8% and 48% +/- 10% with second and third uses, respectively (p less than 0.05). The production of complement component C5a-desarg, as measured by the bioassay granulocyte aggregation, was decreased by 96% +/- 1% and 93% +/- 2% with second and third uses, respectively (p less than 0.05). We investigated the role of the dialyzer disinfectant formaldehyde in decreased neutropenia. In vitro, formaldehyde inhibited granulocyte aggregation and chemotaxis and the dialyzer membrane's ability to generate granulocyte aggregating activity; however, this occurred only at concentrations higher than those likely to obtain in patients. The ability of dialysis membranes to generate granulocyte aggregating activity in plasma was decreased 55% +/- 5% by their prior sequential preincubation in plasma and then formalin (p less than 0.05) and extensive rinsing, which is similar to the circumstances obtaining with dialyzer reuse. Preincubation of membranes in plasma or formalin alone resulted in no change in the membrane's ability to generate granulocyte aggregating activity. We conclude that the exposure of membranes to both plasma and formalin during dialysis and storage is responsible for the decreased C5a-desarg production with reuse, probably because plasma proteins are fixed to the membrane in such a way that interrupts free interaction between the membrane and plasma complement components.

摘要

一项针对10例接受血液透析患者的前瞻性研究表明,复用透析器时中性粒细胞减少和补体激活的情况较少。首次使用时中性粒细胞计数下降95%±5%(标准误),第二次和第三次使用时分别下降66%±8%和48%±10%(p<0.05)。通过生物测定粒细胞聚集来测量的补体成分C5a-去精氨酸的产生,在第二次和第三次使用时分别下降了96%±1%和93%±2%(p<0.05)。我们研究了透析器消毒剂甲醛在减少中性粒细胞减少中的作用。在体外,甲醛抑制粒细胞聚集和趋化作用以及透析器膜产生粒细胞聚集活性的能力;然而,这仅在高于患者体内可能达到的浓度时才会发生。透析膜在血浆中先序贯预孵育然后再用福尔马林处理(p<0.05)以及大量冲洗后,其在血浆中产生粒细胞聚集活性的能力下降了55%±5%,这与透析器复用的情况相似。仅在血浆或福尔马林中对膜进行预孵育,膜产生粒细胞聚集活性的能力没有变化。我们得出结论,透析和储存过程中膜暴露于血浆和福尔马林中是复用导致C5a-去精氨酸产生减少的原因,可能是因为血浆蛋白以某种方式固定在膜上,从而中断了膜与血浆补体成分之间的自由相互作用。

相似文献

1
Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.透析器复用对血液透析中补体激活和中性粒细胞减少的影响。
J Lab Clin Med. 1984 Sep;104(3):304-11.
2
Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.血液透析粒细胞减少症中一种促进黏附的表面糖蛋白表达增加。
N Engl J Med. 1985 Feb 21;312(8):457-62. doi: 10.1056/NEJM198502213120801.
3
Complement activation and neutropenia occurring during cardiopulmonary bypass.体外循环期间发生的补体激活和中性粒细胞减少。
J Thorac Cardiovasc Surg. 1981 Mar;81(3):370-7.
4
Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.血液透析所致粒细胞减少症及肺部白细胞淤滞的逆转:粒细胞对C5adesarg反应选择性下调的一种临床表现
J Clin Invest. 1981 May;67(5):1383-91. doi: 10.1172/jci110166.
5
[Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].[血透中血仿膜、二醋酸纤维素膜和腈纶膜生物相容性的比较]
Acta Med Croatica. 2004;58(1):31-6.
6
On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes.关于血液透析诱导中性粒细胞减少症的机制:一项对五种新的和重复使用的透析膜的研究。
Nephrol Dial Transplant. 1988;3(6):773-83.
7
Dialyzer reuse--part II: advantages and disadvantages.透析器复用——第二部分:优点与缺点
Semin Dial. 2006 May-Jun;19(3):217-26. doi: 10.1111/j.1525-139X.2006.00158.x.
8
Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.牛血浆、血清和乳中C5a/C5a(去精氨酸)的定量分析。
Vet Res. 1998 Jan-Feb;29(1):73-88.
9
Clinical sequelae of complement activation in hemodialysis.血液透析中补体激活的临床后遗症。
Clin Nephrol. 1986;26 Suppl 1:S9-12.
10
Hemodialysis neutropenia and dialyzer reuse: role of the cleansing agent.血液透析性中性粒细胞减少与透析器复用:清洗剂的作用
Uremia Invest. 1984;8(1):17-23. doi: 10.3109/08860228409080978.

引用本文的文献

1
Hemodialysis-Related Complement and Contact Pathway Activation and Cardiovascular Risk: A Narrative Review.血液透析相关的补体和接触途径激活与心血管风险:一项叙述性综述。
Kidney Med. 2021 Jun 9;3(4):607-618. doi: 10.1016/j.xkme.2021.04.006. eCollection 2021 Jul-Aug.
2
The reuse of hemodialyzers: an assessment of safety and potential savings.血液透析器的复用:安全性评估及潜在节省情况
CMAJ. 1993 Jan 15;148(2):175-83.
3
The lungs in uraemia: a review.尿毒症中的肺部病变:综述
J R Soc Med. 1985 Oct;78(10):849-55. doi: 10.1177/014107688507801012.
4
Development of a simple radioimmunoassay for human C3a.一种用于人C3a的简易放射免疫测定法的开发。
Inflammation. 1988 Jun;12(3):265-76. doi: 10.1007/BF00920078.
5
beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.β2微球蛋白淀粉样变性。一种主要影响长期透析患者滑膜和骨骼的全身性淀粉样疾病。
Rheumatol Int. 1990;10(1):1-8. doi: 10.1007/BF02274774.